This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wira, C. R. Articles by Kaushic, C. Search for Related Content PubMed PubMed Citation Articles by Wira, C. R. Articles by Kaushic, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL

Antigen-Presenting Cells in the Female Reproductive Tract: Influence of Estradiol on Antigen Presentation by Vaginal Cells¹

Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756

Address all correspondence and requests for reprints to: Dr. C. R. Wira, Department of Physiology, Dartmouth Medical School, Borwell Building, 1 Medical Center Drive, Lebanon, New Hampshire 03756-0001.

The objective of the present study was to define the afferent arm of the mucosal immune system in the lower female reproductive tract. We report here that antigen presentation by vaginal cells is under hormonal control. When vaginal cells from ovariectomized rats treated with estradiol (0.01–10 µg) were incubated with ovalbumin-specific T cells and ovalbumin, a dose-dependent inhibition of antigen presentation was measured. In time course studies, estradiol given to ovariectomized rats inhibited vaginal cell antigen presentation within 24 h after a single injection, relative to that seen in saline controls. To determine whether changes in antigen presentation were attributable to the effect of estradiol on the number of antigen-presenting cells (APCs) in the vagina, tissues were analyzed by immunohistochemistry. Our findings indicate that estradiol inhibited antigen presentation without affecting the number of major histocompatibility complex class II positive cells and at a time when macrophage/dendritic cells/granulocytes in the vagina increase in response to estradiol treatment. Antibody neutralization studies indicated that antigen presentation by vaginal cells from ovariectomized rats is mediated through class II and involves the expression of transmembrane proteins B7.1 and B7.2. In other studies, vaginal APCs interact with thymus APCs to synergistically enhance antigen presentation under conditions in which vaginal antigen presentation is inhibited by estradiol. Analysis of conditioned media indicates that enhancement of thymus antigen presentation involves the release of a soluble factor(s) into the culture media of vaginal cells. When spleen cells were cocultured with vaginal cells from saline-treated rats, proliferation increased in the presence of concanavalin A and/or phytohemagglutinin and decreased with lipopolysaccharide, relative to spleen cells and mitogen alone. In contrast, when incubated with vaginal cells from estradiol-treated rats, spleen cell proliferation was not affected with concanavalin but was inhibited with phytohemagglutinin and lipopolysaccharide. These studies demonstrate that estradiol regulates antigen presentation by vaginal cells and that vaginal cells, in turn, influence antigen presentation, as well as B and T cell proliferation.

This article has been cited by other articles:

				M. M. Seavey and T. R. Mosmann Paternal Antigen-Bearing Cells Transferred during Insemination Do Not Stimulate Anti-Paternal CD8+ T Cells: Role of Estradiol in Locally Inhibiting CD8+ T Cell Responses J. Immunol., December 1, 2006; 177(11): 7567 - 7578. [Abstract] [Full Text] [PDF]

				D. M. LeBlanc, M. M. Barousse, and P. L. Fidel Jr. Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis. Infect. Immun., June 1, 2006; 74(6): 3213 - 3221. [Abstract] [Full Text] [PDF]

				M. R. Ryan, R. Shepherd, J. K. Leavey, Y. Gao, F. Grassi, F. J. Schnell, W.-P. Qian, G. J. Kersh, M. N. Weitzmann, and R. Pacifici An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency PNAS, November 15, 2005; 102(46): 16735 - 16740. [Abstract] [Full Text] [PDF]

				C. R. Wira, R. M. Rossoll, and R. C. Young Polarized Uterine Epithelial Cells Preferentially Present Antigen at the Basolateral Surface: Role of Stromal Cells in Regulating Class II-Mediated Epithelial Cell Antigen Presentation J. Immunol., August 1, 2005; 175(3): 1795 - 1804. [Abstract] [Full Text] [PDF]

				M. J. Keller, A. Tuyama, M. J. Carlucci, and B. C. Herold Topical microbicides for the prevention of genital herpes infection J. Antimicrob. Chemother., April 1, 2005; 55(4): 420 - 423. [Abstract] [Full Text] [PDF]

				C. T. Teng, C. Beard, and W. Gladwell Differential Expression and Estrogen Response of Lactoferrin Gene in the Female Reproductive Tract of Mouse, Rat, and Hamster Biol Reprod, November 1, 2002; 67(5): 1439 - 1449. [Abstract] [Full Text] [PDF]

				C. R. Wira, M. A. Roche, and R. M. Rossoll Antigen Presentation by Vaginal Cells: Role of TGF{beta} as a Mediator of Estradiol Inhibition of Antigen Presentation Endocrinology, August 1, 2002; 143(8): 2872 - 2879. [Abstract] [Full Text] [PDF]

				T. M. Kish, L. R. Budgeon, P. A. Welsh, and M. K. Howett Immunological Characterization of Human Vaginal Xenografts in Immunocompromised Mice : Development of a Small Animal Model for the Study of Human Immunodeficiency Virus-1 Infection Am. J. Pathol., December 1, 2001; 159(6): 2331 - 2345. [Abstract] [Full Text] [PDF]